← Open Payments lookup

WENDY PRATT: Open Payments

NPI 1225021207 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,541 in 70 payments from 11 companies in 2025. Trend: 2023 $855 · 2024 $743 · 2025 $1,541

Food & beverage: $1,473Education: $68
CompanyPaymentsAmount
GlaxoSmithKline, LLC.31$353
GENZYME CORPORATION10$318
AstraZeneca Pharmaceuticals LP9$218
Regeneron Healthcare Solutions, Inc.9$198
Viatris Specialty LLC4$172
Boehringer Ingelheim Pharmaceuticals, Inc.1$125
Amgen Inc.2$68
Actelion Pharmaceuticals US, Inc.1$40
Insmed, Inc.1$18
Merck Sharp & Dohme LLC1$16

Products named: DUPIXENT, NUCALA, YUPELRI, AIRSUPRA, TRELEGY ELLIPTA, FASENRA, UPTRAVI, TEZSPIRE.

Industry payments across LA — which companies pay providers there.